Capital Markets Day

Cambridge Cognition Holdings PLC
31 May 2023
 

31 May 2023

 

Cambridge Cognition Holdings Plc

("Cambridge Cognition" or the "Company")

 

Capital Markets Day

 

Cambridge Cognition Holdings plc ("the Company"), which develops and markets digital solutions to assess brain health, is pleased to announce that it will be hosting a Capital Markets Day on 14 June 2023 at 14:00 in the Great Room at Central Court, 25 Southampton Buildings, London WC2A 1AL.

The event will feature a series of presentations from Cambridge Cognition's management and senior leadership team focussing on the latest developments in the Company's product and technology portfolios.

To express interest in attending the event please email: cog@investor-focus.co.uk

No material new information or update on current trading will be disclosed at the event.

 

Enquiries:

Cambridge Cognition Holdings Plc

Matthew Stork, Chief Executive Officer

Stephen Symonds, Chief Financial Officer

Tel: 012 2381 0700

press@camcog.com

Panmure Gordon (UK) Limited
(NOMAD and Joint Broker)

Freddy Crossley / Emma Earl / Mark Rogers

Rupert Dearden


Tel: 020 7886 2500

(Corporate Advisory)

(Corporate Broking)

Dowgate Capital Limited (Joint Broker)

David Poutney / James Serjeant

Tel: 020 3903 7715

 

IFC Advisory Limited (Financial PR and IR)

Tim Metcalfe / Graham Herring / Zach Cohen

Tel: 020 3934 6630

cog@investor-focus.co.uk

 

About Cambridge Cognition

Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.

For further information visit www.cambridgecognition.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings